Research Articles
60 results
Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational study
Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need.
Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing.
Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants.
Usefulness of a Non-Streptavidin Bead Technology to Overcome Biotin Interference: Proof of Principle with 25-OH Vitamin D, TSH, and FT4.
The myths behind DOAC measurement: Analyses of prescribing information from different regulatory bodies and a call for harmonization.
The edoxaban-M4 metabolite and measurement of edoxaban by chromogenic assays in human plasma.
The Impact of Strong Inducers on Direct Oral Anticoagulant Levels.
The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs.
Study of in vitro thrombin generation after neutralization of heparin.
Stability of coagulation parameters in plasma samples at room temperature after one freeze/thaw cycle.
Simultaneous assessment of DOACs effect on clot formation and fibrinolysis with the FibWave.
Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method.
Proof of concept of a new scale for the harmonization and the standardization of the ETP-based APC resistance.
Performance of a Qualitative Point-of-Care Strip Test to Detect DOAC Exposure at the Emergency Department: A Cohort-Type Cross-Sectional Diagnostic Accuracy Study.
Overview and Practical Application of Coagulation Assays in Managing Anticoagulation with Direct Oral Anticoagulants (DOACs).
Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk.
Overcoming issues in plasmatic evaluation of direct Factor Xa inhibitors
Optimal wavelength for the clot waveform analysis: Determination of the best resolution with minimal interference of the reagents.
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone.
Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians.
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance.
Influence of C-reactive protein on thrombin generation assay.
Interlaboratory variability of activated protein C resistance using the ETP-based APC resistance assay.
Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women.
Importance of measuring pharmacologically active metabolites of edoxaban: development and validation of an ultra-high-performance liquid chromatography coupled with a tandem mass spectrometry method.
Impact of centrifugation on thrombin generation in healthy subjects and in patients treated with direct oral anticoagulants.
Hormone-induced coagulopathy – Evaluation of the prothrombotic state using a global coagulation assay
Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination.
Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
Evaluation of the analytical performances of FibWave, a new sensitive tool assessing the fibrin clot formation, to measure the effects of anticoagulants.
Evaluation of the DOAC-Stop(R) Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests.
Evaluation of Activated Protein C Resistance Using Thrombin Generation Test.
Effect of tissue factor pathway inhibitor on thrombin generation assay.
Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE.
Development of new methodologies for the chromogenic estimation of betrixaban concentrations in plasma.
Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis.
D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review.
Contraceptifs oraux combinés et thrombo-embolie veineuse: quels sont vriament les risques?
Comprehensive review of the impact of direct oral anticoagulants on thrombophilia diagnostic tests: Practical recommendations for the laboratory.
Concomitant assessment of rivaroxaban concentration and its impact on thrombin generation.
Comparison is not reason: Pitfalls in reporting thrombin generation results in anticoagulated patients.
Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban-treated patients and healthy controls.
Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk.
Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?
Betrixaban: Impact on Routine and Specific Coagulation Assays-A Practical Laboratory Guide.
Association of cardiovascular occlusive events with BCR-ABL tyrosine kinase therapy – Identification, understanding and prediction.
Assessment of low plasma concentrations of apixaban in the periprocedural setting.
Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application.
Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass.
Are the DOAC plasma level thresholds appropriate for clinical decision-making? A reappraisal using thrombin generation testing.
Analytical performance of the endogenous thrombin potential-based activated protein C resistance assay on the automated ST Genesia system.
An update on laboratory assessment for direct oral anticoagulants (DOACs).
